BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2555Biotechnology
$7.74 −$0.80 (-9.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.80 +0.76%
Open$8.51
Prev close$8.54
Day range$7.55 – $8.60
Volume10.25M
Market cap$2.77B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership73.4%-0.97 pts vs. prior quarter
Institutions holding247+0 vs. prior quarter
Insider trades (recent)25 buys / 25 sellsBalanced
Short interest11.81% of floatDays to cover 16.3 · as of 15 Sep 2026
Short-sale volume share18.7%5-day average of daily volume

Short-sale volume as % of daily volume

14%18%22%25%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.56M (5 inflow days, 15 outflow days).

The five largest holders on file together own 48.9% of shares outstanding.

Largest holders

  • Third Security, LLC29.06%
  • Patient Capital Management, LLC5.32%
  • E. Merck KG4.88%
  • William Miller4.86%
  • BlackRock4.79%
  • Randal Kirk3.74%
  • State Street Global Advisors3.35%
  • Diametric Capital, LP2.59%

By investor type

  • VC/PE Fund29.06%
  • Mutual Fund27.99%
  • Individual/Insider11.71%
  • Hedge Fund7.43%
  • Private Company5.54%
  • Public Company3.06%
  • Government Pension Fund0.20%
  • Family Office/Trust0.09%

Reported short interest has fallen from 12.40% to 11.81% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 42,278,237 11.8% 16.3
31 Aug 2026 42,180,337 11.8% 7.9
14 Aug 2026 42,240,157 11.8% 5.9
31 Jul 2026 42,044,362 11.8% 11.1
15 Jul 2026 41,025,860 11.5% 9.6
30 Jun 2026 44,222,506 12.4% 7.6

Discussion

No comments yet — be the first to weigh in on PGEN.

Leave a comment

Scroll to Top